EDNRA and systemic sclerosis: AT1R- and ETAR-autoantibodies have been shown to be more frequently positive in patients with PAH secondary to SSc or other connective tissue disease when compared to patients with idiopathic PAH or chronic thromboembolic pulmonary hypertension (25).